96 results
Page 3 of 5
8-K
EX-10.1
y1o4h iqpr5
7 Jan 21
Entry into a Material Definitive Agreement
7:08am
8-K
EX-10.1
klw69
7 May 20
Apellis Pharmaceuticals Announces Private Placement of Convertible Senior Notes
7:44am
S-8
EX-99.1
0hkewgb5dwnhxk3
27 Feb 20
Registration of securities for employees
12:00am
S-8
uicysvns
27 Feb 20
Registration of securities for employees
12:00am
S-8
nbf3bik j0xro
27 Feb 20
Registration of securities for employees
12:00am
424B5
qvm3i3tap8f94wo6x
9 Jan 20
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
pa6b3
9 Jan 20
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5:22pm
8-K
EX-5.1
c0lu7 20l4bj6ns24c5k
9 Jan 20
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5:22pm
424B5
7qim4lemtx3
7 Jan 20
Prospectus supplement for primary offering
4:19pm
S-3ASR
bye978
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
EX-4.4
ncpcv0gythwjauf
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
EX-4.3
1oiuu804uhya32xsvtd
7 Jan 20
Automatic shelf registration
4:01pm
8-K
EX-10.1
jufonmev
7 Oct 19
Departure of Directors or Certain Officers
4:06pm
POS AM
owb5w 0dt5r06o98
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm